Clinical researchers at Nationwide Children's are committed to identifying new approaches for the prevention, diagnosis and treatment of childhood diseases, taking research discoveries from the lab to the patient's bedside.
Can a Baby on Noninvasive Respiratory Support Be Fed Orally?
Recent studies suggest that orally feeding infants with bronchopulmonary dysplasia who are on nCPAP or nasal cannula may have benefits – and does not necessarily result in aspiration or GERD, as was once feared.
Sensory-focused Constraint Induced Movement Therapy for Infants and Toddlers with Cerebral Palsy
Effective for older children with CP, a randomized clinical trial is studying a modified version of the therapy for infants and toddlers.
Despite Safety Concerns, Nearly 1 in 4 Babies in NICUs Receive Acid Suppressive Medication
Numbers have dropped in recent years, however, as physicians heed warnings.
Neurodevelopmental Impairment in ELBW Babies Predicted by Often-Unreported MRI Finding
More objective, data-driven MRI scoring system revealed gyral maturational delay as a predictor.
Visit Nationwide Children’s at PAS 2016
Learn more about how we are delivering best outcomes for children’s health at booth #915.
Weaning Babies with NAS Better and Faster
Collaboration shows strict adherence improves outcomes for newborns of opioid users.
Extremely Premature Infants Benefit from Early Extubation Attempts
Early attempts are associated with shorter hospital stays and lower incidence of bronchopulmonary dysplasia, even if reintubation is necessary.
What’s new and what’s ahead?
Extremely Premature Babies May Benefit from Proactive, Coordinated Care
Study looks to improve outcomes for neonates born at 23 weeks by taking a proactive approach, including shared decision-making between families and health care providers.
Reducing Central Line Infections in Neonates
CLABSIs dropped nearly 90 percent with quality improvement initiative.
Morgan’s Fund Launches NEC Podcast
Premiere episode features Gail Besner, MD, discussing surgical outcomes, her discovery of HB-EGF, and current research.
Potential Shift in Care for CMV-Infected Neonates
Oral doses of valganciclovir for six months improve long-term hearing and neurodevelopment, causing a shift in care for infants born with the disease.
Ohio Perinatal Research Network